Comparing 10 vendors in Pen Needles Startups across 0 criteria.
Comprehensive Company Analysis - Business strategy, SWOT, financials, growth areas, M&A moves
Market Position & Share Insights - Visual competitive landscape (like the quadrant above)
Segment-level Benchmarking - Product, region, and end-user vertical
Image & Report PDF Downloads - Ready-to-use for presentations and strategy sessions
Demand Generation [Optional Buy] - License quadrant to drive demand & showcase leadership
Summary
The pen needles market has witnessed remarkable growth, driven by technological advancements and increasing demand for self-injectable therapies. As the prevalence of chronic diseases, such as diabetes, continues to rise globally, the need for effective, safe, and convenient medication delivery systems becomes paramount. This market is characterized by a diverse range of products tailored to meet the specific needs of various patient groups, from standard gauge pen needles to more advanced devices like auto-injectors and pre-filled syringes.
The competitive landscape of the pen needles market is predominantly occupied by key players such as Embecta Corp, Novo Nordisk A/S, and B. Braun SE. These market leaders have established a strong presence through strategic product launches, acquisitions, and expansions, ensuring they remain at the forefront of innovation. The major players are continuously expanding their product portfolios and geographic reach to meet the growing demand and tap into emerging markets.
Emerging trends in the pen needles industry are significantly impacting customer businesses. There is a noticeable shift in revenue streams, with technological advancements encouraging the adoption of newer, more efficient pen needle systems. Innovations such as AI-enabled smart features and sensors for real-time feedback are revolutionizing the user experience, pushing companies to innovate continuously. As the market evolves, smaller companies and startups are presented with numerous opportunities to introduce disruptive innovations, influencing the dynamics of the market considerably.
Key Developments
On feb 2023, Montmed Inc. has announced the issuance of a second U.S. patent (No. 11,517,659) for its SiteSmart™ pen needle system. This innovative system aids insulin users in developing and adhering to a structured injection site rotation plan, reducing the risk of lipohypertrophy—a condition resulting from repeated insulin injections at the same site.
Startups in the Market
PromiseMed Medical Devices Inc.: Originating from Canada, PromiseMed stands out as a progressive company with a robust product and business excellence. It is known for its strong partner ecosystem and well-developed marketing channels, fostering growth and innovation.
MHC Medical Products Inc.: This U.S.-based SME is recognized as a responsive company, emphasizing innovative product offerings. It focuses on expanding its portfolio through strategic partnerships and VC funding.
AdvaCare Pharma: Known as a technology disruptor from the U.S., AdvaCare specializes in innovative solutions within the pen needles market. Their focus is on developing products that meet the evolving needs of healthcare professionals.
Wellion: Based in Austria, Wellion is a responsive SME striving to enhance its market position through continuous product development and innovation.
Links Medical Products Inc.: A dynamic U.S. company, Links Medical focuses on specific technologies within the industry and is gradually establishing a strong business foundation.
Montméd: As a Canadian startup in the starting blocks category, Montméd is growing steadily by offering niche products that cater to specific market needs.
1 INTRODUCTION
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.2.2 Market Segmentation
1.2.3 Years Considered
1.2.4 Currency Considered
1.3 Limitations
1.4 Stakeholders
1.5 Summary of Changes
2 MARKET OVERVIEW
2.1 Introduction
2.2 Market Dynamics
2.2.1 Drivers
2.2.1.1 Rising incidence of chronic diseases
2.2.1.2 Favorable reimbursements in certain countries
2.2.1.3 Growing adoption of self-administration
2.2.1.4 Decreasing prices of insulin formulations
2.2.2 Restraints
2.2.2.1 Alternative methods of drug delivery
2.2.2.2 Poor reimbursement scenario in emerging markets
2.2.2.3 Needle anxiety
2.2.3 Opportunities
2.2.3.1 Growing preference for biosimilar drugs
2.2.3.2 Emerging economies to offer highgrowth potential
2.2.3.3 Rising healthcare expenditure on diabetes
2.2.3.4 Implementation of regulations for safety pen needles
2.2.4 Challenges
2.2.4.1 ReUse of pen needles
2.2.4.2 MisUse of injection pens
2.3 Industry Trends
2.3.1 Growing Preference for Safety-Engineered Pen Needles
2.3.2 Rising Adoption of Shorter and Ultra-Thin Needles
2.4 Reimbursement Scenario
2.5 Value Chain Analysis
2.6 Ecosystem Analysis
2.7 Porter’s Five Forces Analysis
2.7.1 Intensity of Competitive Rivalry
2.7.2 Bargaining Power of Suppliers
2.7.3 Bargaining Power of Buyers
2.7.4 Threat of Substitutes
2.7.5 Threat of New Entrants
2.8 Supply Chain Analysis
2.9 Trade Analysis
2.9.1 Trade Analysis of Needles, Catheters, and Cannulae Used in
Medical, Surgical, Dental, or Veterinary Sciences (HS Code
901839)
2.9.2 Export Data (HS Code 901839), 2019–2023
2.9.3 Import Data (HS Code 901839), 2019–2023
2.10 Patent Analysis
2.10.1 Patent Publication Trends for Pen Needles
2.10.2 Insights: Jurisdiction and Top Applicant Analysis
2.11 Technology Analysis
2.11.1 Key Technologies
2.11.1.1 Fluid flow enhancement technology
2.11.1.2 Ultra-thin needle technology
2.11.2 Complementary Technologies
2.11.2.1 Microfabricated needles
2.11.2.2 AI in pen injectors
2.11.3 Adjacent Technologies
2.11.3.1 Autoinjectors
2.12 Key Conferences & Events, 2025–2026
2.13 Adjacent Market Analysis
2.13.1 Autoinjectors Market
2.13.2 Insulin Delivery Devices Market
2.13.3 Injection Pens Market
2.13.4 Needles Market
2.14 Impact of AI/Gen AI on Pen Needles Market
2.15 Trends/Disruptions Impacting Customers’ Business
2.16 Unmet Needs Analysis
2.17 Investment & Funding Scenario
3 COMPETITIVE LANDSCAPE
3.1 Introduction
3.2 Key Player Strategies/Right to Win
3.2.1 Overview of Strategies Adopted By Key Players in Pen Needles
Market
3.3 Revenue Analysis, 2019–2023
3.4 Market Share Analysis, 2023
3.5 Company Evaluation Matrix: Startups/SMEs, 2023
3.5.1 Progressive Companies
3.5.2 Responsive Companies
3.5.3 Dynamic Companies
3.5.4 Starting Blocks
3.5.5 Competitive Benchmarking
3.5.5.1 Detailed list of key startups/SMEs
3.5.5.2 Competitive benchmarking of key startups/SMEs
3.6 Company Valuation & Financial Metrics
3.7 Competitive Scenario
3.7.1 Product Launches & Approvals
3.7.2 Deals
3.7.3 Expansions
3.8 Brand/Product Comparison
4 COMPANY PROFILES
4.1 GLUCORX LIMITED
4.1.1 Business overview
4.1.2 Products/Solutions/Services offered
4.1.3 Recent developments
4.2 SIMPLE DIAGNOSTICS
4.2.1 Business overview
4.2.2 Products/Solutions/Services offered
4.2.3 Recent developments
4.3 WELLION
4.3.1 Business overview
4.3.2 Products/Solutions/Services offered
4.3.3 Recent developments
4.4 LINKS MEDICAL PRODUCTS INC.
4.4.1 Business overview
4.4.2 Products/Solutions/Services offered
4.4.3 Recent developments
4.5 MHC MEDICAL PRODUCTS, LLC
4.5.1 Business overview
4.5.2 Products/Solutions/Services offered
4.5.3 Recent developments
4.6 ADVACARE PHARMA
4.6.1 Business overview
4.6.2 Products/Solutions/Services offered
4.6.3 Recent developments
4.7 MEDEXCEL
4.7.1 Business overview
4.7.2 Products/Solutions/Services offered
4.7.3 Recent developments
4.8 PROMISEMED MEDICAL DEVICES, INC.
4.8.1 Business overview
4.8.2 Products/Solutions/Services offered
4.8.3 Recent developments
4.9 FEEL TECH
4.9.1 Business overview
4.9.2 Products/Solutions/Services offered
4.9.3 Recent developments
4.10 MONTMED
4.10.1 Business overview
4.10.2 Products/Solutions/Services offered
4.10.3 Recent developments
Jan 2021
Canada NewsWire
